Patents by Inventor Y. Tang

Y. Tang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20050256036
    Abstract: The invention relates to pharmaceutical compositions comprising gastrointestinal proliferative factor (GIPF) polynucleotides and polypeptides. The invention further relates to the therapeutic use of GIPF to prevent or treat conditions or disorders associated with the degeneration of the epithelial mucosa.
    Type: Application
    Filed: January 27, 2005
    Publication date: November 17, 2005
    Inventors: Bryan Boyle, Walter Funk, Makoto Kakitani, Takeshi Oshima, Eun Park, Y. Tang, Mikio Yagi, Kazuma Tomizuka
  • Publication number: 20050256044
    Abstract: The invention relates to pharmaceutical compositions comprising gastrointestinal proliferative factor (GIPF) polynucleotides and polypeptides. The invention further relates to the therapeutic use of GIPF to prevent or treat conditions or disorders associated with the degeneration of the epithelial mucosa.
    Type: Application
    Filed: January 27, 2005
    Publication date: November 17, 2005
    Inventors: Bryan Boyle, Walter Funk, Makoto Kakitani, Takeshi Oshima, Eun Park, Y. Tang, Mikio Yagi, Kazuma Tomizuka
  • Publication number: 20050239126
    Abstract: The invention provides human proteases (PRTS) and polynucleotides which identify and encode PRTS. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of PRTS.
    Type: Application
    Filed: June 27, 2005
    Publication date: October 27, 2005
    Inventors: Stephen Todd, Angelo Delegeane, Ameena Gandhi, Danniel Nguyen, April Hafalia, Liam Kearney, Yan Lu, Ernestine Lee, Narinder Chawla, Debopriya Das, Chandra Arvizu, Monique Yao, Deborah Kallick, Vicki Elliott, Li Ding, Henry Yue, Roopa Reddy, Dyung Lu, Jayalaxmi Ramkumar, Junming Yang, Catherine Tribouley, Neil Burford, Mariah Baughn, Preeti Lal, Mark Borowsky, Farrah Khan, Rajagopal Gururajan, Y. Tang, Janice Au-Young, Bridget Warren, Roberto Hernandez, Brendan Duggan
  • Publication number: 20050239060
    Abstract: The present invention provides novel nucleic acids, novel polypeptide sequences encoded by these nucleic acids and uses thereof.
    Type: Application
    Filed: April 12, 2002
    Publication date: October 27, 2005
    Inventors: Y. Tang, Chenghua Liu, Vinod Asundi, Jie Zhang, Feiyan Ren, Rui-hong Chen, Qing Zhao, Tom Wehrman, Aidong Xue, Yonghong Yang, Jian-Rui Wang, Ping Zhou, Yunqing Ma, Dunrui Wang, Zhiwei Wang, Radoje Drmanac
  • Publication number: 20050227277
    Abstract: The invention provides human apoptosis proteins (APOP) and polynucleotides which identify and encode APOP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with expression of APOP.
    Type: Application
    Filed: May 20, 2005
    Publication date: October 13, 2005
    Inventors: Y. Tang, Jennifer Hillman, Henry Yue, Mariah Baughn, Yalda Azimzai, Janice Au-Young
  • Publication number: 20050226812
    Abstract: Certain cells, including various types of cancer cells, express KIRHy proteins. Targeting using KIRHy polypeptides, nucleic acids encoding for KIRHy polypeptides and anti-KIRHy antibodies provides a method of killing or inhibiting that growth of cancer cells that express the KIRHy protein. Methods of therapy and diagnosis of disorders associated with KIRHy protein-expressing cells, such as acute myelogenous leukemia (AML), are described.
    Type: Application
    Filed: October 8, 2004
    Publication date: October 13, 2005
    Applicant: NUVELO, Inc.
    Inventors: Peter Emtage, Y. Tang
  • Publication number: 20050227280
    Abstract: The invention provides human proteases (PRTS) and polynucleotides which identify and encode PRTS. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of PRTS.
    Type: Application
    Filed: May 31, 2005
    Publication date: October 13, 2005
    Inventors: Angelo Delegeane, Preeti Lal, April Hafalia, Chandra Arvizu, Narinder Chawla, Liam Kearney, Catherine Tribouley, Farrah Khan, Monique Yao, Mariah Baughn, Yalda Azimzai, Vicki Elliott, Danniel Nguyen, Ameena Gandhi, Junming Yang, Roberto Hernandez, Jennifer Policky, Dyung Aina Lu, Roopa Reddy, Henry Yue, Y. Tang
  • Publication number: 20050221342
    Abstract: The present invention provides novel nucleic acids, novel polypeptide sequences encoded by these nucleic acids and uses thereof.
    Type: Application
    Filed: October 22, 2004
    Publication date: October 6, 2005
    Applicant: NUVELO, Inc.
    Inventors: Y. Tang, Vinod Asundi, Ping Zhou, Aidong Xue, Feiyan Ren, Jie Zhang, Jian-Rui Wang, Yonghong Yang, Qing Zhao, Ryle Goodrich, Chenghua Liu, Radoje Drmanac, Yunqing Ma, Zhiwei Wang, Tom Wehrman
  • Publication number: 20050214795
    Abstract: The invention provides human transcriptional regulator molecules (HTRM) and polynucleotides which identify and encode HTRM. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating or preventing disorders associated with expression of HTRM.
    Type: Application
    Filed: October 26, 2004
    Publication date: September 29, 2005
    Inventors: Jennifer Hillman, Olga Bandman, Preeti Lal, Henry Yue, Roopa Reddy, Y. Tang, Edward Gerstin, Chandra Arvizu, Mariah Baughn, Yalda Azimzai, Dyung M. Lu
  • Publication number: 20050208524
    Abstract: The invention provides full-length expressed genetic markers (FLEXGEM) and polynucleotides which identify and encode FLEXGEM. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with expression of FLEXGEM.
    Type: Application
    Filed: November 18, 2004
    Publication date: September 22, 2005
    Inventors: Henry Yue, Y. Tang, Preeti Lal, Roopa Reddy, Mariah Baughn, Junming Yang, Yalda Azimzai
  • Publication number: 20050208498
    Abstract: Certain cells, including types of cancer cells such as KIRHy1, are capable of expressing KIRHy1 mRNA. Targeting using KIRHy1 polypeptides, nucleic acids encoding for KIRHy1 polypeptides and anti-KIRHy1 antibodies provides a method of killing or inhibiting that growth of cancer cells that express the KIRHy1 protein. Methods of therapy and diagnosis of disorders associated with KIRHy1 protein-expressing cells, such as B cell lymphoma, are described.
    Type: Application
    Filed: December 2, 2003
    Publication date: September 22, 2005
    Applicant: NUVELO, Inc.
    Inventors: Peter Emtage, Ping Zhou, Vinod Asundi, Y. Tang, Radoje Drmanac
  • Publication number: 20050208488
    Abstract: The invention provides novel polynucleotides and polypeptides encoded by such polynucleotides and mutants or variants thereof that correspond to a novel human von Willebrand/Thrombospondin-like polypeptide. These polynucleotides comprise nucleic acid sequences isolated from cDNA library from human fetal brain (Hyseq clone identification number 15258924). Other aspects of the invention include vectors containing processes for producing novel human von Willebrand/Thrombospondin-like polypeptides, and antibodies specific for such polypeptides.
    Type: Application
    Filed: December 22, 2000
    Publication date: September 22, 2005
    Inventors: Bryan Boyle, Nancy Mize, Matthew Arterburn, Y. Tang, Chenghua Liu, Radoje Drmanac
  • Publication number: 20050202422
    Abstract: The present invention provides novel nucleic acids, novel polypeptide sequences encoded by these nucleic acids and uses thereof.
    Type: Application
    Filed: November 8, 2002
    Publication date: September 15, 2005
    Inventors: Y. Tang, Chenghua Liu, Vinod Asundi, Rui-Hong Chen, Feiyan Ren, Dunrui Wang, Jian-Rui Wang, Chongjun Xu, Aidong Xue, Yonghong Yang, Jie Zhang, Qing Zhao, Ping Zhou, Ryle Goodrich, Radoje Drmanac
  • Publication number: 20050202479
    Abstract: The invention provides novel polynucleotides and polypeptides encoded by such polynucleotides and mutants or variants thereof that correspond to novel insulin growth factor-like (IGFL) polypeptides. Other aspects of the invention include vectors containing processes for producing novel IGFL polypeptides, and antibodies specific for such polypeptides.
    Type: Application
    Filed: February 2, 2005
    Publication date: September 15, 2005
    Applicant: NUVELO, Inc.
    Inventors: Peter Emtage, Tianhua Hu, Y. Tang
  • Publication number: 20050202474
    Abstract: The invention provides human phosphodiesterases (HPDE) and polynucleotides which identify and encode HPDE. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of HPDE.
    Type: Application
    Filed: January 21, 2005
    Publication date: September 15, 2005
    Inventors: Mariah Baughn, Dyung Lu, Henry Yue, Y. Tang, Danniel Nguyen
  • Publication number: 20050196754
    Abstract: The present invention provides novel nucleic acids, novel polypeptide sequences encoded by these nucleic acids and uses thereof.
    Type: Application
    Filed: March 30, 2001
    Publication date: September 8, 2005
    Inventors: Radoje Drmanac, Chenghua Liu, Y Tang
  • Publication number: 20050192215
    Abstract: The invention provides novel polynucleotides and polypeptides encoded by such polynucleotides and mutants or variants thereof that correspond to the novel polynucleotides and polypeptides. Other aspects of the invention include vectors containing processes for producing novel polypeptides, and antibodies specific for such polypeptides.
    Type: Application
    Filed: December 2, 2002
    Publication date: September 1, 2005
    Inventors: Malabika Ghosh, Y Tang, Jian-Rui Wang, Zhiwei Wang, Qing Zhao, Chongjun Xu, Julio Mulero, Bryan Boyle
  • Publication number: 20050186569
    Abstract: A Various embodiments of the invention provide human nucleic acid-associated proteins (NAAP) and polynucleotides which identify and encode NAAP. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of NAAP.
    Type: Application
    Filed: October 29, 2002
    Publication date: August 25, 2005
    Inventors: Shanya Becha, Mark Borowsky, Neil Burford, Narinder Chawla, Vicki Elliott, Brooke Emerling, Ian Forsythe, Kimberly Gietzen, Ann Gorvad, Jennifer Griffin, April Hafalia, Craig Ison, Preeti Lal, Ernestine Lee, Sally Lee, Soo Lee, Joseph Marquis, Jayalaxmi Ramkumar, William Sprague, Anita Swarnakar, Y. Tang, Bridget Warren, Junming Yang, Henry Yue, Yeganeh Zebarjadian
  • Publication number: 20050181404
    Abstract: The invention provides human protease molecules (HUPM) and polynucleotides which identify and encode HUPM. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for treating or preventing disorders associated with expression of HUPM.
    Type: Application
    Filed: January 27, 2005
    Publication date: August 18, 2005
    Applicant: Incyte Pharmaceuticals, Inc.
    Inventors: Olga Bandman, Jennifer Hillman, Henry Yue, Karl Guegler, Neil Corley, Y. Tang, Purvi Shah
  • Publication number: 20050181415
    Abstract: The invention provides human drug metabolizing enzymes (DME) and polynucleotides which identify and encode DME. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of DME.
    Type: Application
    Filed: March 14, 2005
    Publication date: August 18, 2005
    Inventors: Junming Yang, Mariah Baughn, Neil Burford, Janice Au-Young, Dyung Lu, Roopa Reddy, Huijun Ring, Jennifer Hillman, Henry Yue, Yalda Azimzai, Monique Yao, Ameena Gandhi, Danniel Nguyen, Y. Tang, Preeti Lal, Olga Bandman